| Officer | Age | In this role | Source |
|---|---|---|---|
|
Reid Waldman
Also a director
Chief Executive Officer and Director
|
31 | Not stated | |
|
Dominic Carrano
Chief Financial Officer
|
40 |
Since 2025
1 year
|
|
|
Tim Durso
Chief Technical Officer
|
36 |
Since 2026
this year
|
|
|
Mark Neumann
Chief Commercial and Strategy Officer
|
62 |
Since 2025
1 year
|
|
|
Michael V. Greco
General Counsel
|
55 |
Since 2025
1 year
|
|
|
David Hollander
Chief R&D Officer
Title from the Form 4 dated Sep 1, 2026
|
Not stated | Not stated | |
|
Timothy August Durso
Chief Technical Officer
Title from the Form 4 dated Aug 17, 2026
|
Not stated | Not stated |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. Veradermics, Inc has not filed one with the SEC.
Loading...